Evidence summary for use of rapid antigen testing for screening or surveillance of asymptomatic individuals to limit transmission of SARS-CoV-2
dc.contributor.author | Health Information and Quality Authority (HIQA) | |
dc.date.accessioned | 2021-09-21T15:18:28Z | |
dc.date.available | 2021-09-21T15:18:28Z | |
dc.date.issued | 2021-09-20 | |
dc.identifier.uri | http://hdl.handle.net/10147/630431 | |
dc.description | This evidence synthesis was produced by the Health Technology Assessment team and used to inform advice provided to NPHET to address the following policy question: “What is the emerging evidence with regard to the effectiveness of rapid antigen testing of asymptomatic populations, to limit the spread of SARS-CoV-2?” | en_US |
dc.language.iso | en | en_US |
dc.publisher | Health Information and Quality Authority (HIQA) | en_US |
dc.relation.url | https://www.hiqa.ie/reports-and-publications/health-technology-assessment/rapid-antigen-testing-asymptomatic | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | rapid antigen testing | en_US |
dc.subject | transmission | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | SCREENING | en_US |
dc.title | Evidence summary for use of rapid antigen testing for screening or surveillance of asymptomatic individuals to limit transmission of SARS-CoV-2 | en_US |
dc.type | Report | en_US |
dc.language.rfc3066 | English | |
refterms.dateFOA | 2021-09-21T15:18:30Z |